Overview
Deafness-opticoacoustic nerve atrophy-dementia syndrome is an extremely rare genetic condition that affects the nervous system in multiple ways. It is sometimes referred to by its Orphanet designation (ORPHA:3213) and involves a combination of hearing loss (deafness), damage to the nerves that connect the eyes and ears to the brain (optic and acoustic nerve atrophy), and progressive decline in mental function (dementia). The condition was originally described in a small number of families, making detailed knowledge about it limited. People with this syndrome typically experience progressive hearing loss due to deterioration of the acoustic (hearing) nerves, along with vision problems caused by wasting of the optic nerves. Over time, affected individuals also develop cognitive decline, meaning they gradually lose the ability to think clearly, remember things, and carry out daily tasks. The combination of sensory losses and dementia can be profoundly disabling. Because this condition is so rare, there are currently no specific treatments that target the underlying cause. Management focuses on supportive care, including hearing aids or cochlear implants for hearing loss, low-vision aids, and cognitive support services. Genetic counseling is recommended for affected families. Research into the exact genetic cause and potential therapies remains very limited.
Key symptoms:
Progressive hearing lossVision loss due to optic nerve damageDecline in memory and thinking ability (dementia)Difficulty understanding speechLoss of balance or coordinationDifficulty with daily tasks over timePersonality or behavior changesDifficulty communicatingSocial withdrawal due to sensory losses
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Deafness-opticoacoustic nerve atrophy-dementia syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Deafness-opticoacoustic nerve atrophy-dementia syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Deafness-opticoacoustic nerve atrophy-dementia syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Deafness-opticoacoustic nerve atrophy-dementia syndrome.
Community
No community posts yet. Be the first to share your experience with Deafness-opticoacoustic nerve atrophy-dementia syndrome.
Start the conversation →Latest news about Deafness-opticoacoustic nerve atrophy-dementia syndrome
No recent news articles for Deafness-opticoacoustic nerve atrophy-dementia syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the expected rate of progression for hearing loss, vision loss, and cognitive decline in my case?,Are there any genetic tests that could help identify the exact cause in our family?,What assistive devices or therapies are available to help with hearing and vision loss?,Are there any medications that might slow cognitive decline?,Should other family members be tested or screened?,What support services are available for caregivers?,Are there any research studies or clinical trials we could participate in?
Common questions about Deafness-opticoacoustic nerve atrophy-dementia syndrome
What is Deafness-opticoacoustic nerve atrophy-dementia syndrome?
Deafness-opticoacoustic nerve atrophy-dementia syndrome is an extremely rare genetic condition that affects the nervous system in multiple ways. It is sometimes referred to by its Orphanet designation (ORPHA:3213) and involves a combination of hearing loss (deafness), damage to the nerves that connect the eyes and ears to the brain (optic and acoustic nerve atrophy), and progressive decline in mental function (dementia). The condition was originally described in a small number of families, making detailed knowledge about it limited. People with this syndrome typically experience progressive h
How is Deafness-opticoacoustic nerve atrophy-dementia syndrome inherited?
Deafness-opticoacoustic nerve atrophy-dementia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.